GNFT - Inventiva files for IPO June, 19 2020 05:01 PM GENFIT S.A. Fresh off positive results from a mid-stage study evaluating its lead drug in nonalcoholic steatohepatitis (NASH), French biotech Inventiva S.A. (IVA) has filed a preliminary prospectus for a $90M IPO.More news on: Genfit SA, CymaBay Therapeutics, Inc., Inventiva S.A., Healthcare stocks news, IPO News, , Read more ...